KPC PharmaceuticalsInc Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 3yrs |
Recent management updates
Recent updates
Does KPC PharmaceuticalsInc (SHSE:600422) Have A Healthy Balance Sheet?
Dec 12
Investors Holding Back On KPC Pharmaceuticals,Inc. (SHSE:600422)
Nov 18Is KPC Pharmaceuticals,Inc. (SHSE:600422) Trading At A 42% Discount?
Sep 30These 4 Measures Indicate That KPC PharmaceuticalsInc (SHSE:600422) Is Using Debt Safely
Sep 11KPC PharmaceuticalsInc (SHSE:600422) Will Pay A Larger Dividend Than Last Year At CN¥0.20
Jul 25Investors Still Waiting For A Pull Back In KPC Pharmaceuticals,Inc (SHSE:600422)
Jun 25We Think KPC PharmaceuticalsInc (SHSE:600422) Can Stay On Top Of Its Debt
Jun 04KPC PharmaceuticalsInc's (SHSE:600422) Profits May Not Reveal Underlying Issues
Mar 28CEO
KPC PharmaceuticalsInc has no CEO, or we have no data on them.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director | 1.9yrs | no data | no data | |
| Director | 1.2yrs | no data | no data | |
| Chairman | 1.9yrs | no data | no data | |
| Independent Director | 3yrs | CN¥100.00k | no data | |
| Independent Director | 6.1yrs | CN¥100.00k | no data | |
| Director | 1.9yrs | no data | no data | |
| Employee Supervisor | 6.1yrs | no data | no data | |
| Employee Supervisor | 6.1yrs | no data | no data | |
| Vice Chairman | less than a year | no data | no data | |
| Independent Director | 3yrs | CN¥100.00k | no data | |
| Supervisor | 3.7yrs | no data | no data |
3.0yrs
Average Tenure
52yo
Average Age
Experienced Board: 600422's board of directors are considered experienced (3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 07:40 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
KPC Pharmaceuticals,Inc. is covered by 24 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Pei Hui Tang | Chasing Securities |
| Pei Cheng | China Galaxy Securities Co., Ltd. |